142892-37-3 Usage
General Description
Endo-8-Methyl-8-azabicyclo[3.2.1]octane-3-methanol, also known as dexmethylphenidate, is a psychoactive drug. It is a central nervous system stimulant used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. Dexmethylphenidate acts by increasing the levels of dopamine and norepinephrine in the brain, which enhances focus, attention, and impulse control. It is sold under the brand names Focalin and Attenade. Common side effects of dexmethylphenidate include insomnia, decreased appetite, and increased blood pressure. It is important to use this medication as prescribed and under the guidance of a healthcare professional to minimize potential risks and side effects.
Check Digit Verification of cas no
The CAS Registry Mumber 142892-37-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,2,8,9 and 2 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 142892-37:
(8*1)+(7*4)+(6*2)+(5*8)+(4*9)+(3*2)+(2*3)+(1*7)=143
143 % 10 = 3
So 142892-37-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H17NO/c1-10-8-2-3-9(10)5-7(4-8)6-11/h7-9,11H,2-6H2,1H3
142892-37-3Relevant articles and documents
NOVEL COMBINATION OF THERAPEUTIC AGENTS
-
Page/Page column 15-16, (2009/04/25)
Novel combinations of a muscarinic acetylcholine receptor antagonist and a beta 2 agonist and/or a corticosteroid for inhaled administration via the nose or mouth, and methods of using them are provided herein.
High π-route reactivity in the tropene system. Absence of a nitrogen acceleration effect
Murr, Brown L.,Parkhill, Billy J.,Nickon, Alex
, p. 4845 - 4862 (2007/10/02)
Solvolyses of a suitably constructed tropene tosylate and its unsaturated carbocyclic analog show that the amino function, despite its suitable spatial location, does not enhance the π-route assistance but reduces it slightly.
